Gender-Dysphoria / Gender-Incongruence
Key Points
Key Points
- Gender-dysphoric/gender-incongruent persons should receive a safe and effective hormone regimen that will suppress the body’s sex hormone secretion, determined at birth and manifested at puberty, and maintain levels of sex steroids within the normal range for the person’s affirmed gender.
- Hormone treatment is not recommended for pre-pubertal gender-dysphoric/gender-incongruent persons.
- For the care of youths during puberty and older adolescents, an expert multi-disciplinary team comprised of medical professionals and mental health professionals should manage treatment.
- For adult gender-dysphoric/gender-incongruent persons, the treating clinicians (collectively) should have expertise in transgender-specific diagnostic criteria, mental health, primary care, hormone treatment, and surgery, as needed by the patient.
- All individuals seeking gender-affirming medical treatment should receive information and counsel on options for fertility preservation prior to initiating puberty suppression in adolescents and prior to treating with hormonal therapy in both adolescents and adults.
- Removal of gonads may be considered when high doses of sex steroids are required to suppress the body’s secretion of hormones, and/or to reduce steroid levels in advanced age.
- During sex steroid treatment, clinicians should monitor, in both transgender males (female to male) and/or transgender females (male to female), prolactin, metabolic disorders, and bone loss, as well as cancer risks in individuals who have not undergone surgical treatment.
Table 1. Definitions of Terms Used in This Guideline
| Term | Definition |
|---|---|
| Biological sex, biological male or female | These terms refer to physical aspects of maleness and femaleness. As these may not be in line with each other (e.g., a person with XY chromosomes may have female-appearing genitalia), the terms biological sex and biological male or female are imprecise and should be avoided. |
| Cisgender | This means not transgender. An alternative way to describe individuals who are not transgender is “non-transgender people.” |
| Gender-affirming (hormone) treatment | See “Gender reassignment." |
| Gender dysphoria (GD) | This is the distress and unease experienced if gender identity and designated gender are not completely congruent (see Table 2). In 2013, the American Psychiatric Association released the fifth edition of the DSM-5, which replaced “gender identity disorder” with “gender dysphoria” and changed the criteria for diagnosis. |
| Gender expression | This refers to external manifestations of gender, expressed through one’s name, pronouns, clothing, haircut, behavior, voice, or body characteristics. Typically, transgender people seek to make their gender expression align with their gender identity, rather than their designated gender. |
| Gender identity/ experienced gender | This refers to one’s internal, deeply held sense of gender. For transgender people, their gender identity does not match their sex designated at birth. Most people have a gender identity of man or woman (or boy or girl). For some people, their gender identity does not fit neatly into one of those two choices. Unlike gender expression (see above), gender identity is not visible to others. |
| Gender identity disorder | This is the term used for GD/GI in previous versions of DSM (see “Gender dysphoria”). The ICD-10 still uses the term for diagnosing children, but the upcoming ICD-11 has proposed using “gender incongruence of childhood.” |
| Gender incongruence (GI) | This is an umbrella term used when the gender identity and/or gender expression differs from what is typically associated with the designated gender. Gender incongruence is also the proposed name of the gender identity-related diagnoses in ICD-11. Not all individuals with gender incongruence have gender dysphoria or seek treatment. |
| Gender variance | See “Gender incongruence.” |
| Gender reassignment | This refers to the treatment procedure for those who want to adapt their bodies to the experienced gender by means of hormones and/or surgery. This is also called gender-confirming or gender-affirming treatment. |
| Gender-reassignment surgery (gender-confirming/gender-affirming surgery) | These terms refer only to the surgical part of gender-confirming/gender-affirming treatment. |
Diagnosis
...gnosis...
...ion of Youth and Adult...
...ety (ES) advises that only trained me...
...that only MHPs who meet the follow...
...ises that decisions regarding the socia...
...nds against puberty-blocking and gender-affirming...
...mmends that clinicians inform and co...
.... DSM-5 Criteria for Gender Dysphoria...
...Criteria for TranssexualismHaving trouble vie...
Treatment
...atment
...tment of Adolescents...
...hat adolescents who meet diagnostic criteri...
...at clinicians begin pubertal hormone supp...
...mends that, where indicated, GnRH analogues...
...olescents who request sex hormone treatment (given...
We recognize that there may be comp...
...S suggests monitoring clinical pubertal developm...
...l Therapy for Transgender Ad...
ES recommends that clinicians confirm...
...recommends that clinicians evaluate...
...suggests that clinicians measure hormone levels...
...ests that endocrinologists provide educati...
...4. Criteria for Gender-Affirming Hormone...
...eria for Gender-Affirming Hormone Therapy...
...er Stages of Breast Development and Male...
...aseline and Follow-Up Protocol During Suppression...
...otocol Induction of Puberty I...
...Baseline and Follow-up Protocol During In...
...Medical Risks Associated With Sex Hormone...
...Hormone Regimens in Transgender Persons Ha...
...Masculinizing Effects in Transgender Male...
...eminizing Effects in Transgender Fem...
...tcome Prevention and Long-Term Care...
...suggests regular clinical evaluation fo...
...iodically monitoring prolactin levels in tr...
...ggests that clinicians evaluate transgender perso...
...recommends that clinicians obtain bone min...
...hat transgender females with no known increase...
...hat transgender females treated with es...
ES advises that clinicians determine the med...
...toring of Transgender Persons on Gender-Affirmin...
...le 15. Monitoring of Transgender Persons on Ge...
...Reassignment and Gender Confirmation...
...mends that a patient pursue genital gender-affir...
...hat clinicians approve genital gender...
...the clinician responsible for endocrine treatmen...
...s that clinicians refer hormone-treated transgen...
...clinicians delay gender-affirming gen...
...s that clinicians determine the timi...
...iteria for Gender-Affirming Surgery that...